Tetrahydrocortisone

Tetrahydrocortisone

SCHEMBL2837657

CN(C)C=O.C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ G6PD P11413 4/20 0.69
▸ CYP3A4 P08684 4/20 0.69
▸ GABRA1 P14867 6/20 0.53
▸ GABRB2 P47870 6/20 0.53
▸ GABRG2 P18507 3/20 0.52
▸ GABRB3 P28472 3/20 0.52
▸ GABRA2 P47869 3/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ GLA P06280 1/20 0.52
▸ HSD17B10 Q99714 6/20 0.49
▸ LMNA P02545 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ NR3C1 P04150 2/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ SHBG P04278 1/20 0.49
▸ SERPINA6 P08185 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrocortisone SCHEMBL4111245 0.93 G6PD (0.79) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL1184193 0.93 G6PD (0.79) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL1332665 0.93 G6PD (0.79) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL1184192 0.93 G6PD (0.79) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL193711 0.93 G6PD (0.79) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL5610354 0.93 G6PD (0.79) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL11169159 0.93 G6PD (0.77) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL6461669 0.93 G6PD (0.77) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL5139991 0.93 G6PD (0.77) G6PDCYP3A4GABRA1GABRB2GABRG2
Tetrahydrocortisone SCHEMBL8366487 0.93 G6PD (0.77) G6PDCYP3A4GABRA1GABRB2GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107758724-A A kind of Cu of morphology controllable2Preparation method nanocrystalline O 温州大学 2018-03-06 — — CN claimed
CN-103748272-B Manufacture the device and method of fiber 得克萨斯大学体系董事会 2019-11-19 — — CN disclosed
CN-107190362-B A kind of high-purity ZnO/BiVO4The preparation method of heterogeneous micro belt 宁波工程学院 2019-11-19 — — CN disclosed
CN-110437230-A A kind of three-level aminated compounds and biphosphine ligand, wherein mesosome and preparation method SHANGHAI INST ORGANIC CHEMISTRY CAS 2019-11-12 — — CN disclosed
CN-106637159-B A kind of chemical plating fluid, preparation method and a kind of method of Chemical Plating of Non metal Material 比亚迪股份有限公司 2019-11-08 — — CN disclosed
CN-110407734-A A kind of 2,3,3- tri-methyl indole system nonlinear optical crystal and its preparation method and purposes UNIV TIANJIN TECHNOLOGY 2019-11-05 — — CN disclosed
CN-110364661-A Isolating membrane and energy storage device 宁德新能源科技有限公司 2019-10-22 — — CN disclosed
CN-107354586-B Gamma-polyglutamic acid-polyacrylonitrile composite nanofiber membrane and preparation method thereof 南京工业大学 2019-10-22 — — CN disclosed
CN-110344271-A A kind of waterproof calico coating process 湖州五兴达丝绸整理有限公司 2019-10-18 — — CN disclosed
CN-107043561-B The product of polymer coating compositions and coating 阿里斯特医疗有限责任公司 2019-10-11 — — CN disclosed
CN-1060778-C Cephalosporin derivatives HOFFMANN LA ROCHE (CH) 2001-01-17 — — CN disclosed
CN-1268137-A Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders DU PONT PHARM CO (US) 2000-09-27 — — CN disclosed
WO-2000018740-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-04-06 — — WO disclosed
CN-1238688-A Thiol sulfonamide metalloprotease inhibitors MONSANTO CO (US) 1999-12-15 — — CN disclosed
CN-1219936-A New triazolopurines, method of preparing them and their use as drugs BOEHRINGER INGELHEIM KG (DE) 1999-06-16 — — CN disclosed
EP-0887340-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 1998-12-30 — — EP disclosed
EP-0674636-B1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS ZENECA LTD (GB) 1998-05-20 — — EP disclosed
CN-1065070-A 11 beta-aryl-4-estrenes of 6,7-sex change SCHERING AG (DE) 1992-10-07 — — CN disclosed
EP-0051828-A1 N-benzoyl-alpha-anilino alkane carboxylic acids, salts and esters thereof, process for producing the same and pharmaceutical preparations containing the same A. Nattermann & Cie. GmbH (DE) 1982-05-19 — — EP disclosed
EP-0021293-A2 4-Substituted thio-1-beta-D-ribofuranosylpyrazolo(3,4-D) pyrimidines, processes for their preparation, pharmaceutical formulations and medical uses THE WELLCOME FOUNDATION LIMITED (GB) 1981-01-07 — — EP disclosed
Send feedback